Mucosal Vaccines, Adjuvants & Delivery

14-16 September 2016, CHUVUniversity of Lausanne, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Day Three

Final Conference Programme | Friday 16th September 2016

SESSION 8:
ADJUVANTS

Moderator: Ed Lavelle (Trinity College Dublin, Dublin, Ireland)

09.00-09.30
‘Polymer and microemulsion adjuvants enhance the immune response conferred by mucosal vaccines in mice and chicken’
Heloise Imbault, Juliette Ben Arous, Nicolas Versillé, Sebastien Deville and Laurent Dupuis (SEPPIC, Paris La Défense Puteaux, France)

09.30-10.00
‘A novel adjuvanted capsule based strategy for oral vaccination against enteric bacterial pathogens’
Stephanie Longet 1, Christopher Davitt 1, Edel McNeela 1, Vincenzo Aversa 3, Joshua Tobias 2, Michael Lebens 2, Monica Rosa 3, Jan Holmgren 2, Ivan Coulter 3 and Ed C. Lavelle 1 (1 Trinity College Dublin, Dublin, Ireland; 2 University of Gothenburg, Gothenburg, Sweden; 3 Sigmoid Pharma Ltd, Invent Centre, Dublin City University, Dublin, Ireland)

10.00-10.20
‘Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer’
Shee Eun Lee, Seol Hee Hong, Vivek Verma, Youn Suhk Lee, Tra-My Nu Duong, Kwangjoon Jeong, Saji Uthaman, Young Chul Sung, Jae-Tae Lee, In-Kyu Park, Jung-Joon Min and Joon Haeng Rhee (Chonnam National University Medical School, Gwangju, Republic of Korea)

10.20-10.50
Coffee Break & Posters

SESSION 9:
IMMUNOGENICITY

Moderator: Eric Cox (Ghent University, Merelbeke, Belgium)

10.50-11.20
‘High immunogenicity of reverse transcriptases of HIV-1 clade A and B in intradermally gene-immunized mice’
E. Starodubova 1,2,3, S. Petkov 3, J. Jansons 4,5, A. Latanova 2,3,6, A. Kilpelainen 3, M. Krawiec 3, A. Vilmane 3,5, S. Sasinovich 7, P. Warholm 8 and M. Isaguliants 3,5 (1 Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, Russia; 2 WA Engelhardt Institute of Molecular Biology, Moscow, Russia; 3 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; 4 Biomedical Research and Study Center, Riga, Latvia; 5 Riga Stradins University, Riga, Latvia; 6 Gamaleja Research Center of Epidemiology and Microbiology, Moscow, Russia; 7 The Republican Research and Practical Centre for Epidemiology and Microbiology, Minsk, Belarus; 8 Science for Life Laboratory, Stockholm University, Stockholm, Sweden)

11.20-11.50
‘Microbiota-regulated, natural IgA confers protection against oral enterotoxin challenge’
Craig McEntee, Rachel M. McLoughlin and Ed C. Lavelle (Trinity College Dublin, Dublin, Ireland)

11.50-12.20
‘Near infra-red fluorescent protein iRFP670 as an in vivo imaging reporter for delivery and immunogenic performance of naked DNA vaccines’
Juris Janssons 2, S. Petkov 1,2, J. Jansons 3, D. Skrastina 3, M. Abakumov 4, I. Gordeychuk 5, A. Latanova 1,6, A. Dovbenko 3, A. Strods 3 ,M. Kalis 2, Y. Moriizumi 7, P. Bankovsky 8, V. Verkhusha 9 and M. Isaguliants 1,2 (1 Karolinska Institutet, Stockholm, Sweden; 2 Riga Stradins University, Riga, Latvia; 3 Latvian Biomedical Research and Study Center, Riga, Latvia; 4 Pirogov Russian National Research Medical University, Moscow, Russia; 5 Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, Russia; 6 Gamaleja Research Center of Epidemiology and Microbiology, Moscow, Russia; 7 BEX Co., Ltd, Tokyo, Japan; 8 Bioscience Media, Riga, Latvia; 9 Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, USA)

12.20-13.30
Lunch Break & Posters Breakdown

SESSION 10:
SHORT POSTER PRESENTATIONS (PART 2)

Moderator: Richard Walker (PATH, Washington, USA)

Poster 101
13.30-13.45

‘Seminal plasma exposures strengthen vaccine responses in the female reproductive tract mucosae’
Romain Marlin 1,2,3, Marie-Thérèse Nugeyre 1,2,3, Matteo Parenti 1, Nathalie Dereuddre-Bosquet 1, Françoise Barré-Sinoussi 3,4, Gabriella Scarlatti 3,5, Roger Le Grand 1,3 and Elisabeth Menu 1,2,3 (1 Université Paris Sud, Inserm U 1184, Fontenay-Aux-Roses, France; 2 MISTIC Group, Institut Pasteur, Paris, France; 3 Vaccine Research Institute, Créteil, France; 4 Institut Pasteur, Paris, France; 5 San Raffaele Scientific Institute, Milan, Italy)

Poster 102
13.45-14.00

‘Advax, a mucosal adjuvant for whole inactivated influenza virus vaccine’
Jasmine Tomar 1, H.P. Patil 2, W.F. Tonnis 1, R.Vanbever 2, N. Petrovsky 3, A. Huckriede 4, H.W. Frijlink 1 and W.L.J. Hinrichs 1 (1 University of Groningen, Groningen, The Netherlands; 2 Universite Catholique de Louvain, Brussels, Belgium; 3 Vaxine Pty Ltd, Flinders Medical Center, Adelaide, Australia; 4 University Medical Center Groningen, Groningen, The Netherlands)

Poster 104
14.00-14.15

‘High cellular immunogenicity in mice of a prototype multicomponent DNA vaccine based on HIV-1 clade A enzymes’
Latanova Anastasia 1,2,3, Petkov Stefan 3, Athina Kilpeläinen 3, Juris Jansons 4, Olga Krotova 1, Anda Vilmane 4, Starodubova Elizaveta 2,3,5 and Isaguliants Maria 1,3,4,5 (1 NF Gamaleja Research Center of Epidemiology and Microbiology, Moscow, Russia; 2 Engelhardt Institute of Molecular Biology, Moscow, Russia; 3 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; 4 Riga Stradins University, Riga, Latvia; 5 MP Chumakov Institute of Poliomyelitis and Viral Encephalitides, Moscow, Russia)

 

Poster 106
14.15-14.30

‘Immunological evaluation of poly[di(sodium carboxylatoethylphenoxy)phosphazene (PCEP) and avian beta defensin as adjuvants in experimental in ovo vaccine formulations against inclusion body hepatitis virus infection in chickens’
Mishal Sarfraz, Suresh K.Tikoo, Andy Potter, Volker Gerdts, Colette Wheler and Arshud Dar (Vaccine and Infectious Disease Organization – International Vaccine Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada)

14.30-14.40
Closing Remarks & Departure
Richard Walker (PATH, Washington DC, USA)

* This final programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.

 

MUCOVAD 2016 Delegates

Login details will be supplied after you have registered for the event.


MUCOVAD 2016 Sponsors

  • Vaxart
  • Aldevron
  • NatureGeneTherapy.com
  • Inovio Pharmaceuticals
  • Mucosis
  • Matrivax
  • DNAvaccine.com

MUCOVAD 2016 Downloads

MUCOVAD 2016 Leaflet

MUCOVAD 2016 Mailing List

Name
E-mail Address
What is 3+2-1?